Catalyst
Slingshot members are tracking this event:
Actinium's (ATNM) Interim Results of Iomab-B in Acute myeloid leukemia (AML) from Pivotal Phase 3 SIERRA Trial due for Monday, October 28th
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ATNM | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 28, 2019
Occurred Source:
https://ir.actiniumpharma.com/press-releases/detail/343/actinium-announces-positive-interim-results-from-iomab-b
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sierra, Bone Marrow Transplantation, Iomab-b, Acute Myeloid Leukemia
